Keiko Mitamura

The whole blood transcriptional regulation landscape in 465 COVID-19 infected samples from Japan COVID-19 Task Force

M. Kanai, Y. Okada, S. Fuke, 2022, Nature Communications.

DOCK2 is involved in the host genetics and biology of severe COVID-19

M. Kanai, Y. Kamatani, Y. Okada, 2022, Nature.

Age-Stratified Seroprevalence of SARS-CoV-2 Antibodies before and during the Vaccination Era, Japan, February 2020–March 2022

Y. Kawaoka, Mutsumi Ito, A. Yasuhara, 2022, Emerging infectious diseases.

Newly developed artificial intelligence algorithm for COVID-19 pneumonia: utility of quantitative CT texture analysis for prediction of favipiravir treatment effect

Y. Ohno, H. Toyama, Hidekazu Hattori, 2022, Japanese Journal of Radiology.

Characteristics of hospitalized patients with COVID-19 during the first to fifth waves of infection: a report from the Japan COVID-19 Task Force

M. Kanai, Y. Okada, S. Fuke, 2022, BMC infectious diseases.

Mapping the human genetic architecture of COVID-19

Mattia G. Bergomi, Christopher M. DeBoever, Matthew A. Wiles, 2021, Nature.

Multi-omics of NET formation and correlations with CNDP1, PSPB, and L-cystine levels in severe and mild COVID-19 infections

Y. Kawaoka, M. Gritsenko, L. Bramer, 2023, Heliyon.

Mapping the human genetic architecture of COVID-19

Mattia G. Bergomi, Christopher M. DeBoever, Matthew A. Wiles, 2021, Nature.

Single-cell analyses and host genetics highlight the role of innate immune cells in COVID-19 severity

M. Kanai, Y. Okada, S. Fuke, 2023, Nature Genetics.

Trivalent inactivated influenza vaccine effective against influenza A(H3N2) variant viruses in children during the 2014/15 season, Japan

Takao Takahashi, Michiko Myokai, C. Kawakami, 2016, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

A second update on mapping the human genetic architecture of COVID-19

M. A. Hakim Newton, Jack D. Sanders, Jonathan H. Morgan, 2022, Nature.

Clinical Evaluation of the Accuracy of the Panbio™ COVID-19/Flu A&B Rapid Panel: A Combination Antigen Rapid Diagnostic Test for the Omicron Variant and Influenza A Virus.

H. Yamagishi, M. Yamazaki, Keiko Mitamura, 2024, Viral immunology.